iPath Inverse S&P 500 VIX Short-Term Futures
IVOP
IVOP was delisted on the 23rd of March, 2018.
3 hedge funds and large institutions have $1.18M invested in iPath Inverse S&P 500 VIX Short-Term Futures in 2014 Q2 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 3 → 3 (0)
13% less capital invested
Capital invested by funds: $1.36M → $1.18M (-$181K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$202K |
IVOP Hedge Fund Activity: Q2 2014 in Review
3 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in iPath Inverse S&P 500 VIX Short-Term Futures (IVOP) for Q2 2014, worth a combined $1.18M — down 13% from $1.36M a quarter earlier.
Fund positioning in IVOP was balanced in Q2 2014: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was Susquehanna International Group, cutting an estimated $202K.
- 3 institutional investors held iPath Inverse S&P 500 VIX Short-Term Futures (IVOP) as of Q2 2014, unchanged from Q1 2014.
- Funds reported $1.18M of iPath Inverse S&P 500 VIX Short-Term Futures stock for Q2 2014, down 13% quarter-over-quarter.
- 0 funds opened new iPath Inverse S&P 500 VIX Short-Term Futures positions in Q2 2014 and 0 closed out.
- The largest iPath Inverse S&P 500 VIX Short-Term Futures seller in Q2 2014 was Susquehanna International Group, an estimated $202K sold.
Based on aggregated 13F filings for Q2 2014.